Opportunity Information: Apply for PAR 22 162

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is offering a discretionary funding opportunity titled "Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)" under Funding Opportunity Number PAR 22 162. This program uses a cooperative agreement mechanism (U01), which typically means the award is not just a standard grant with minimal federal involvement; instead, it usually includes an active scientific partnership or substantial programmatic involvement from NCI staff during the project period. The focus is explicitly non-clinical-trial research, so projects should be epidemiologic and observational in nature rather than testing interventions in a way that meets the NIH definition of a clinical trial.

At the center of this opportunity is support for cancer epidemiology research conducted within established cohort studies. In this context, "established" means the cohort has already met its initial planned recruitment goals, so the FOA is not primarily about launching brand-new cohorts or still trying to finish enrollment. NCI is looking for hypothesis-driven research that makes strong scientific use of existing cohort infrastructure and data, while also supporting the practical work that keeps a cohort valuable over time. That includes cohort maintenance, ongoing participant follow-up, and making the cohort's resources available for broader scientific use through appropriate sharing practices. The intention is to keep mature cohorts scientifically productive and to ensure the investments already made in these cohorts continue to pay off through new discoveries.

The research scope is broad across the cancer control continuum, meaning applicants can target questions ranging from cancer etiology and risk factors to prevention, early detection, survivorship, outcomes, and other population-level cancer control topics. The key expectation is that the application proposes clear, hypothesis-based analyses or research aims that can be carried out using the cohort's data and/or biospecimens, and that the plan aligns with continued follow-up and stewardship of the cohort resource. In other words, the FOA is not just funding stand-alone analyses; it is also supporting the ongoing operations that keep an established cohort current, linkable, and scientifically accessible, including resource sharing that allows the cohort to contribute beyond a single investigative team.

Eligibility is broad and includes many types of U.S. and non-U.S. organizations. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; other Native American tribal organizations; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status; for-profit organizations (other than small businesses); and small businesses. The announcement also calls out additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-domestic (non-U.S.) entities or foreign organizations. This wide eligibility is consistent with the fact that major cohort studies and their scientific collaborators often span different sectors and, in some cases, countries.

Key administrative details provided include the CFDA number 93.393 (an NIH/NCI assistance listing tied to cancer-related programs), an original closing date of February 28, 2025, and a creation date for the opportunity record of April 13, 2022. The source data does not specify an award ceiling or the expected number of awards in the fields shown, so applicants would typically need to consult the full FOA text or NIH documentation for any budget caps, typical award sizes, project period expectations, and review considerations.

In practical terms, a strong application under this FOA would present a well-justified scientific question (or set of questions) that the established cohort is uniquely positioned to answer, along with a solid plan for maintaining and leveraging the cohort over time. That usually means demonstrating the cohort's readiness (recruitment complete), the quality and relevance of its data collection and follow-up, and a clear approach to data and resource sharing so the cohort functions as a durable platform for cancer epidemiology research rather than a closed dataset used once and set aside.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393.
  • This funding opportunity was created on 2022-04-13.
  • Applicants must submit their applications by 2025-02-28. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 22 162

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: HEAL Initiative: Oral Complications Arising from Pharmacotherapies to Treat Opioid Use Disorders (R01 Clinical Trial Not Allowed)

Previous opportunity: Bureau of Land Management Utah Cultural and Paleontological Resources Management

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 22 162

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 22 162) also looked into and applied for these:

Funding Opportunity
Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed) Apply for PAR 22 153

Funding Number: PAR 22 153
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71 Clinical Trial Not Allowed) Apply for PAR 22 152

Funding Number: PAR 22 152
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) Apply for PAR 22 151

Funding Number: PAR 22 151
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed) Apply for RFA DA 23 040

Funding Number: RFA DA 23 040
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Pathogenic Mechanisms influencing Blood Brain Barrier function in HIV and Substance Use Disorders (R01 Clinical Trial Optional) Apply for RFA DA 23 012

Funding Number: RFA DA 23 012
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) Apply for PAR 22 182

Funding Number: PAR 22 182
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) Apply for PAR 22 183

Funding Number: PAR 22 183
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional) Apply for RFA CA 22 027

Funding Number: RFA CA 22 027
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Workshops on Computational and Analytical Research Methods (R25 - Clinical Trial Not Allowed) Apply for RFA DA 23 027

Funding Number: RFA DA 23 027
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Stimulants and HIV: Addressing Contemporary and Recurring Epidemics (R61/R33 - Clinical Trial Required) Apply for RFA DA 23 008

Funding Number: RFA DA 23 008
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $400,000
Treatments for Lewy Body Dementias and Frontotemporal Dementias--Exploratory Clinical Trial (U01 Clinical Trial Required) Apply for RFA NS 22 056

Funding Number: RFA NS 22 056
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $400,000
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 22 187

Funding Number: PAR 22 187
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 22 188

Funding Number: PAR 22 188
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
A Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention (P01 Clinical Trial Not Allowed) Apply for RFA AI 22 038

Funding Number: RFA AI 22 038
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,000,000
Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - Clinical Trial Not Allowed) Apply for RFA DA 23 015

Funding Number: RFA DA 23 015
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) Apply for PAR 22 181

Funding Number: PAR 22 181
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) Apply for RFA DA 23 020

Funding Number: RFA DA 23 020
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) Apply for RFA DA 23 019

Funding Number: RFA DA 23 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) Apply for PAR 22 165

Funding Number: PAR 22 165
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) Apply for PAR 22 164

Funding Number: PAR 22 164
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 22 162", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: